Intravenous methylprednisolone pulse therapy in severe ankylosing spondylitis
✍ Scribed by Gregorio Mintz; Rubén D. Enríquez; Ulises Mercado; Elsa J. Robles; F. Javier Jiménez; Gaspar Gutiérrez
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 230 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Objective. To assess the role of genes and the environment in determining the severity of ankylosing spondylitis. Methods. One hundred seventy-three families with >1 case of ankylosing spondylitis were recruited (120 affected sibling pairs, 26 affected parent-child pairs, 20 families with both firs
The prognosis for children with chronic interstitial lung disease is poor and the mortality rate is high, especially in infants. This explains the many therapeutical protocols which have been proposed and investigated by several authors. In the present work, we evaluated the response of three infant
We describe a patient with primary Sjogren's syndrome who developed myositis. The results of muscle pathologic analysis before and after treatment with monthly pulses of cyclophosphamide (intravenously), are presented. Late-onset myositis has been described in patients with Sjogren's syndrome (SS)